Joseph Michael Fitzgerald - 16 Feb 2024 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP & Group Pres, Cardiology
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
16 Feb 2024
Transactions value $
-$374,647
Form type
4
Filing time
20 Feb 2024, 21:03:39 UTC
Previous filing
16 Feb 2024
Next filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +3.96K +2.12% $0.00 191K 16 Feb 2024 Direct F1
transaction BSX Common Stock Tax liability -$119K -1.81K -0.95% $65.82 189K 16 Feb 2024 Direct
transaction BSX Common Stock Options Exercise $0 +4.17K +2.21% $0.00 193K 17 Feb 2024 Direct F1
transaction BSX Common Stock Tax liability -$135K -2.06K -1.07% $65.82 191K 17 Feb 2024 Direct
transaction BSX Common Stock Options Exercise $0 +3.71K +1.94% $0.00 195K 18 Feb 2024 Direct F2
transaction BSX Common Stock Tax liability -$120K -1.83K -0.94% $65.82 193K 18 Feb 2024 Direct
holding BSX Common Stock 68K 16 Feb 2024 By 401(k) F3
holding BSX Common Stock 4.89K 16 Feb 2024 By Child F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -3.96K -33.33% $0.00 7.92K 16 Feb 2024 Common Stock 3.96K Direct F1, F5
transaction BSX Restricted Stock Units Options Exercise $0 -4.17K -50% $0.00 4.17K 17 Feb 2024 Common Stock 4.17K Direct F1, F6
transaction BSX Deferred Stock Units Options Exercise $0 -3.71K -100% $0.00* 0 18 Feb 2024 Common Stock 3.71K Direct F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
F3 Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F4 The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F6 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F7 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.